Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
4,804 total articles
Broadcom (AVGO) is sitting on durable AI and enterprise software exposure, exceptional returns on capital and $29B of free cash flow. At ~$314.56 and a market cap near $1.49T, the stock carries lofty headline multiples (roughly 60x earnings) but the balance sheet, cash generation and structural AI demand give multi-year visibility that, when paired…
Sprouts Farmers Market (SFM) looks cheap on multiple operating metrics relative to its growth runway and cash generation. I’m upgrading to a Buy: the setup combines a sub-9x EV/EBITDA, strong free cash flow (about $468M last reported), sub-0.1x debt/equity and a beaten-down share price that discounts a meaningful recovery in comps. Trade plan inclu…
Netflix looks set to deliver an earnings beat on 04/16/2026. Primary drivers: accelerating monetization from ad tiers and recent price increases, new live-sports and distribution deals that lift ARPU, and healthy cash generation that cushions margin upside. Technicals and short-interest dynamics favor a momentum-driven move into the print. This tra…
Yara International (YARIY) looks inexpensive at a $14.8B market cap and a PE of ~10.8. A persistent upswing in urea and ammonia markets, plus project optionality in clean ammonia, creates asymmetric upside. This trade targets a re-rating into the $36 area over the next 180 trading days while limiting downside with a $25.50 stop.
Occidental combines a durable cash-flow profile, reasonable leverage and a large, supportive shareholder in Warren Buffett. At roughly $63 today, the stock is trading at mid-cycle multiples but offers asymmetric upside if oil stays elevated or geopolitical risk boosts prices. This trade idea lays out an actionable plan, catalysts and the risks that…
XPEL (XPEL) offers a compelling risk-reward: a $1.2B market-cap specialty automotive aftermarket company posting record quarterly revenue, healthy free cash flow, and drawing increased activist interest. With valuation metrics that leave room for multiple expansion if growth continues, this trade targets $60 with a disciplined stop at $39 and a 180…
AngioDynamics (ANGO) is showing genuine top-line traction—recent results and segment strength support upside—but recent leadership upheaval and thin free cash flow leave the stock volatile. We outline a mid-term swing trade to capture a recovery while protecting capital if uncertainty widens.
Oracle is currently trading at a valuation that understates the commercial traction of Oracle Cloud Infrastructure (OCI) and its multicloud hooks. With a $553 billion backlog cited by analysts, strong ROE and an actionable path to deleveraging, the risk/reward favors reopening a long position. This trade idea sets a clear entry at $146.38, a $220 u…
TRX Gold (TRX) looks poised for a momentum trade if price clears the $1.55 supply area on meaningful volume. Production and revenue growth at Buckreef, plus a benign technical structure (MACD turning positive, price above key EMAs), make TRX a conditional long. This is a medium-risk swing trade with a clear entry at $1.55, stop at $1.20 and target …
Broadcom is executing a low-profile but high-impact play in custom AI accelerators for hyperscalers. Strong cash generation, healthy balance sheet metrics and embedded partnerships create a high-upside setup. This trade idea outlines a long entry at current levels with a clear stop and two asymmetric targets over a 180 trading-day horizon.
Hess Midstream (HESM) offers an attractive entry point for income-oriented traders looking to capture a near-8% yield backed by healthy free cash flow and asset-based growth. At $38.79 the unit sits between its 50-day and 20-day averages, trading at a reasonable EV/EBITDA of ~7.2 with $728M of trailing free cash flow. This is a trade that leans lon…
Brookfield Asset Management (BAM) is generating meaningful free cash flow but trades at stretched multiples that have compressed in the last year. We lay out a mid-term (45 trading days) trade to capture a potential re-rate as recent asset wins and steady FCF provide a floor, while protecting capital if multiples continue to contract.
Robinhood is presenting a compelling entry after a brutal pullback. With improving crypto volumes, a $1.5B buyback, a growing prediction-market initiative, and a still-plentiful retail flow pipeline (SpaceX retail distribution chatter), the setup favors a patient long. We upgrade to a buy for a long-term position (180 trading days) with specific en…
Palantir is trading like an AI market-share winner. Revenue acceleration from generative AI, strong commercial growth, and mission-critical government footholds underpin a long trade. Valuation is rich, so position sizing and a clear stop are essential. Trade plan: enter $148.45, stop $118.00, target $220.00, horizon 180 trading days.
Intel has delivered clear operational wins recently: full control of Fab 34, improving technical momentum, and stronger market interest in its AI/data-center story. The company’s market cap sits around $252B and price action has already re-rated the stock. This trade idea views the current price as a window to short a priced-in rally on the mid-ter…
Toro's Professional segment momentum, plus management's operational productivity initiatives and healthy free cash flow, create a compelling mid-term trade. At $92.72 the valuation is reasonable (P/E ~27, EV/EBITDA 16.1) for a company with $660.6M in free cash flow, 23% ROE and an enterprise value under $10B. Take a measured long with a tight stop …
Celestica is set up for a continuation higher after recent partnership news with AMD, improving technical momentum, and solid cash generation. The stock trades near $295 with a PE around 41, strong ROE, and positive MACD — a swing trade sized for a mid-term run toward the $360 area with a disciplined stop below $265.
UiPath has slid into a pragmatic buy zone after a heavy pullback in 2026. The stock trades at a reasonable multiple vs. cash flow, recent product releases put it squarely in the agentic AI narrative, and technicals show a contained risk profile. This is a tactical long with defined risk, sized for a mid-term (45 trading days) swing and optional ext…
Microsoft’s recent pullback has compressed sentiment, creating a tactical long opportunity. The trade here is to initiate a position near $440 with a $520 target and a $400 stop, banking on renewed AI-driven cloud revenue and margin stabilization over the next six months. This is a measured, size-weighted entry for investors willing to ride through…
AMC Networks (AMCX) just closed multiple debt maneuvers that unlock up to $50M in buybacks and move heavy near-term maturities out to 2032. With free cash flow of $272M, an EV/EBITDA of ~4.2 and a market cap near $306M, the stock screens cheap. I’m upgrading to bullish and laying out a long-term (180 trading days) trade plan: entry $7.18, stop $5.3…
MarketAxess (MKTX) is a high-quality fintech franchise trading at about $6.1B market cap. The trade idea is a conditional long: enter around current levels while sizing for a mid-term turnaround in margins and volumes. Catalyst set includes trading volume rebounds, product adoption (Axess IQ), and continued buybacks/dividends. Risks include protoco…
VALE is trading at $16.20 with a market cap of roughly $73.5B and a 7.9% cash yield. Market commentary suggests an implied EV/EBITDA of ~4.8x for Vale - a level that looks attractive for a diversified iron-ore and nickel producer if commodity prices stabilize. This is a tactical mid-term long: entry $16.20, stop $14.75, target $18.50 over ~45 tradi…
Google's TurboQuant created headline volatility for memory names, but Micron's fundamentals - revenue momentum, strong cash generation, low leverage, and HBM scarcity - argue the sell-off is overdone. This trade targets $540 with disciplined risk controls and a 46-180 trading day horizon.
Johnson & Johnson's diversified medtech and pharmaceutical engine gives investors a low-volatility way to play a potential $25 billion multiple myeloma upside by 2030. At $243, the stock trades at ~22x earnings with a $585B market cap, 63 years of dividend raises and ~$19.3B in free cash flow — metrics that support a long-term buy. Trade plan provi…
Hut 8 is transitioning from crypto-mining legacy assets to large-scale AI and HPC infrastructure. The company's announced multi-gigawatt expansion program - anchored by strategic partners and backed by a clean balance sheet and a sizable digital-asset treasury - makes the current pullback an entry opportunity. This trade idea lays out precise entry…
